​

Vericel (VCEL) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Vericel Revenue Highlights

Latest Revenue (Y)

$237.22M

Latest Revenue (Q)

$75.38M

Main Segment (Y)

MACI Implants And Kits

Vericel Revenue by Period

Vericel Revenue by Year

DateRevenueChange
2024-12-31$237.22M20.10%
2023-12-31$197.52M20.17%
2022-12-31$164.37M5.24%
2021-12-31$156.18M25.77%
2020-12-31$124.18M5.37%
2019-12-31$117.85M29.71%
2018-12-31$90.86M42.13%
2017-12-31$63.92M17.54%
2016-12-31$54.38M6.28%
2015-12-31$51.17M77.69%
2014-12-31$28.80M151457.89%
2013-12-31$19.00K-9.52%
2012-12-31$21.00K16.67%
2011-12-31$18.00K-79.78%
2010-06-30$89.00K-51.10%
2009-06-30$182.00K-65.13%
2008-06-30$522.00K-23.80%
2007-06-30$685.00K-20.63%
2006-06-30$863.00K-5.06%
2005-06-30$909.00K-30.18%
2004-06-30$1.30M54.27%
2003-06-30$844.00K-3.76%
2002-06-30$877.00K-2.45%
2001-06-30$899.00K-21.83%
2000-06-30$1.15M30.53%
1999-06-30$881.00K253.82%
1998-06-30$249.00K-37.75%
1997-06-30$400.00K-75.00%
1996-06-30$1.60M-

Vericel generated $237.22M in revenue during NA 2024, up 20.10% compared to the previous quarter, and up 201.29% compared to the same period a year ago.

Vericel Revenue by Quarter

DateRevenueChange
2024-12-31$75.38M30.17%
2024-09-30$57.91M9.96%
2024-06-30$52.66M2.69%
2024-03-31$51.28M-21.10%
2023-12-31$65.00M42.59%
2023-09-30$45.58M-0.74%
2023-06-30$45.92M11.96%
2023-03-31$41.02M-22.16%
2022-12-31$52.69M36.69%
2022-09-30$38.55M4.06%
2022-06-30$37.05M2.69%
2022-03-31$36.07M-24.20%
2021-12-31$47.59M37.92%
2021-09-30$34.51M-12.69%
2021-06-30$39.52M14.32%
2021-03-31$34.57M-23.57%
2020-12-31$45.23M40.21%
2020-09-30$32.26M61.18%
2020-06-30$20.01M-24.98%
2020-03-31$26.68M-32.27%
2019-12-31$39.39M29.15%
2019-09-30$30.50M16.63%
2019-06-30$26.15M19.90%
2019-03-31$21.81M-30.40%
2018-12-31$31.34M39.37%
2018-09-30$22.48M18.27%
2018-06-30$19.01M5.46%
2018-03-31$18.03M-22.80%
2017-12-31$23.35M63.74%
2017-09-30$14.26M-15.89%
2017-06-30$16.95M81.10%
2017-03-31$9.36M-43.35%
2016-12-31$16.52M51.18%
2016-09-30$10.93M-14.77%
2016-06-30$12.82M-9.11%
2016-03-31$14.11M-8.51%
2015-12-31$15.42M36.35%
2015-09-30$11.31M-16.78%
2015-06-30$13.59M25.27%
2015-03-31$10.85M-26.23%
2014-12-31$14.71M52.27%
2014-09-30$9.66M117.92%
2014-06-30$4.43M100.00%
2014-03-31--100.00%
2013-12-31$8.00K100.00%
2013-09-30--100.00%
2013-06-30$3.00K-62.50%
2013-03-31$8.00K-57.89%
2012-12-31$19.00K100.00%
2012-09-30-100.00%
2012-06-30--100.00%
2012-03-31$2.00K100.00%
2011-12-31--100.00%
2011-09-30$9.00K100.00%
2011-06-30--100.00%
2011-03-31$9.00K100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31--100.00%
2009-12-31$16.00K-78.08%
2009-09-30$73.00K5.80%
2009-06-30$69.00K18.97%
2009-03-31$58.00K107.14%
2008-12-31$28.00K3.70%
2008-09-30$27.00K-81.88%
2008-06-30$149.00K-26.24%
2008-03-31$202.00K-

Vericel generated $75.38M in revenue during Q4 2024, up 30.17% compared to the previous quarter, and up 165.37% compared to the same period a year ago.

Vericel Revenue Breakdown

Vericel Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21Dec 20
MACI Implants And Kits$197.31M$164.80M$131.97M$111.55M-
NexoBrid----$2.20M

Vericel's latest annual revenue breakdown by segment (product or service), as of Dec 24: MACI Implants And Kits (100.00%).

Quarterly Revenue by Product

Product/ServiceMar 25Dec 24Sep 24Jun 24Mar 24Dec 23Jun 23Mar 23Sep 22Jun 22Mar 22Sep 21Jun 21Mar 21Sep 20Sep 19Jun 19Mar 19Sep 18Jun 18
MACI Implants And Kits$46.30M$68.34M$44.66M$44.13M$40.18M$94.27M$36.34M$34.19M------------
MACI Implants And Kits Member--------$31.01M$28.61M$26.00M---------
MACI Implants and Kits, and Epicel-----------$33.72M$38.68M$33.63M$31.02M-----
Product---------------$30.50M$26.15M$21.81M$22.48M$19.01M

Vericel's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: MACI Implants And Kits (100.00%).

Vericel Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
BPMCBlueprint Medicines$508.82M$149.41M
VCELVericel$237.22M$75.38M
DAWNDay One Biopharmaceuticals$131.16M$29.21M
RGNXREGENXBIO$83.33M$89.01M
STOKStoke Therapeutics$36.55M$22.61M
MRUSMerus$36.13M$9.14M
SNDXSyndax Pharmaceuticals$23.68M$20.04M
CYTKCytokinetics$18.47M$16.93M
CLGNCollPlant Bio$10.96M$98.00K
RLAYRelay Therapeutics$10.01M$7.68M
IDYAIDEAYA Biosciences$7.00M$7.00M
IPSCCentury Therapeutics$6.59M$109.16M
KROSKeros Therapeutics$3.55M$3.04M
XFORX4 Pharmaceuticals$2.56M$28.81M
CRNXCrinetics Pharmaceuticals$1.04M-
CMRXChimerix$212.00K$129.00K
RVMDRevolution Medicines--
XNCRXencor-$70.02M
DYNDyne Therapeutics--
TERNTerns Pharmaceuticals--
PLRXPliant Therapeutics--
MREOMereo BioPharma Group--

VCEL Revenue FAQ

What is Vericel’s yearly revenue?

Vericel's yearly revenue for 2024 was $237.22M, representing an increase of 20.10% compared to 2023. The company's yearly revenue for 2023 was $197.52M, representing an increase of 20.17% compared to 2022. VCEL's yearly revenue for 2022 was $164.36M, representing an increase of 5.24% compared to 2021.

What is Vericel’s quarterly revenue?

Vericel's quarterly revenue for Q4 2024 was $75.38M, a 30.17% increase from the previous quarter (Q3 2024), and a 15.97% increase year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $57.9M, a 9.96% increase from the previous quarter (Q2 2024), and a 27.04% increase year-over-year (Q3 2023). VCEL's quarterly revenue for Q2 2024 was $52.66M, a 2.69% increase from the previous quarter (Q1 2024), and a 14.68% increase year-over-year (Q2 2023).

What is Vericel’s revenue growth rate?

Vericel's revenue growth rate for the last 3 years (2022-2024) was 44.33%, and for the last 5 years (2020-2024) was 91.03%.

What are Vericel’s revenue streams?

Vericel's revenue streams in c 24 are MACI Implants And Kits

What is Vericel’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Vericel was MACI Implants And Kits. This segment made a revenue of $197.31M, representing 100.00% of the company's total revenue.